Niagen Bioscience Inc

NASDAQ: NAGE · Real-Time Price · USD
10.01
0.30 (3.09%)
At close: Aug 15, 2025, 3:59 PM
10.00
-0.10%
After-hours: Aug 15, 2025, 06:19 PM EDT

Niagen Bioscience Inc Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
8.55M -4.94M -16.54M -27.13M
Depreciation & Amortization
1.48M 1.71M 1.88M 1.63M
Stock-Based Compensation
3.66M 4.75M 5.74M 6.2M
Other Working Capital
147K 1.66M -875K -1.21M
Other Non-Cash Items
-4.71M 977K -167K -124K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
3.13M 4.62M -6.01M -4.73M
Operating Cash Flow
12.11M 7.12M -15.1M -24.16M
Capital Expenditures
-163K -148K -334K -409K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
20K 5K n/a n/a
Investing Cash Flow
-143K -143K -334K -409K
Debt Repayment
-11K -15K -16K -31K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-52K -75K -77K 9.38M
Financial Cash Flow
5.37M -90K 7.65M 36.09M
Net Cash Flow
17.34M 6.88M -7.78M 11.52M
Free Cash Flow
11.95M 6.97M -15.43M -24.57M